CDSCO

GSK India has received a positive recommendation from the Subject Expert Committee, SEC, of CDSCO for inactivated influenza vaccine, split virion vaccine. The SEC recommended that permission may be granted for ages more than 64 years.

Inactivated influenza, split virion vaccine sold under brand name Fluarix Tetra in India which helps to protect from influenza (flu). It works by exposure to a small dose of the flu virus which helps the body to develop immunity against the disease. It will not treat an existing flu virus infection.

Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients.

The Central Drugs Standard Control Organisation(CDSCO) under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India.

The Central Drugs Laboratory, Kolkata is the national statutory laboratory of the Government of India for quality control of Drug and Cosmetics and is established under the Indian Drug & Cosmetics Act, 1940. It is the oldest quality control laboratory of the Drug Control Authorities in India. It functions under the administrative control of the Director-General of Health Services in the Ministry of Health and Family Welfare.

CENTRAL DRUGS STANDARD CONTROL ORGANIZATION, Under the Drug and Cosmetics Act, the regulation of manufacture, sale and distribution of Drugs is primarily the concern of the State authorities while the Central Authorities are responsible for approval of New Drugs, Clinical Trials in the country, laying down the standards for Drugs, control over the quality of imported Drugs, coordination of the activities of State Drug Control Organisations and providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.